HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

cannabinor

a selective cannabinoid 2 receptor agonist

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Terpenes: 1461
    - Cannabinoids: 5901
      - cannabinor: 1

Experts

1.	Alroy, Iris: 1 article (02/2011)
2.	Andersson, Karl-Erik: 1 article (02/2011)
3.	Downs, Thomas R: 1 article (02/2011)
4.	Gratzke, Christian: 1 article (02/2011)
5.	Hedlund, Petter: 1 article (02/2011)
6.	Limberg, Brian J: 1 article (02/2011)
7.	Rosenbaum, Jan S: 1 article (02/2011)
8.	Stief, Christian G: 1 article (02/2011)
9.	Streng, Tomi: 1 article (02/2011)

Related Diseases

1.

Urethral Obstruction

02/01/2011 - "In rats with partial urethral obstruction treated daily for 14 days with cannabinor bladder weight was lower, the ability to empty the bladder was preserved and nonvoiding contraction frequency was low compared to those in controls. "
02/01/2011 - "Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction."
02/01/2011 - "A total of 24 female Sprague-Dawley® rats with surgically created partial urethral obstruction received daily intraperitoneal injections of 3 mg/kg cannabinor (12) or saline as controls (12) for 2 weeks. "
02/01/2011 - "We studied the effects of chronic treatment with the novel selective cannabinoid 2 receptor agonist cannabinor (Procter & Gamble Pharmaceuticals, Cincinnati, Ohio) on bladder function in conscious rats with partial urethral obstruction and on the functional properties of isolated detrusor muscle. "

Related Drugs and Biologics

1.	Cannabinoids

Related Therapies and Procedures

1.	Intraperitoneal Injections